![Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1332ad61-1612-4599-87d3-f24b3014c44f/ijc33969-toc-0001-m.jpg)
Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library
![Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer | Laboratory Investigation Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer | Laboratory Investigation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41374-022-00804-9/MediaObjects/41374_2022_804_Fig1_HTML.png)
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer | Laboratory Investigation
Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression | PLOS ONE
![Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12915-014-0072-6/MediaObjects/12915_2014_Article_72_Fig2_HTML.jpg)
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text
![Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352304220301628-gr4.jpg)
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
![HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes – reclassifying cases in the equivocal category - Holzschuh - 2017 - Histopathology - Wiley Online Library HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes – reclassifying cases in the equivocal category - Holzschuh - 2017 - Histopathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/85eaffed-7c8f-4dbc-b8df-3024b33d753d/his13253-fig-0006-m.png)
HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes – reclassifying cases in the equivocal category - Holzschuh - 2017 - Histopathology - Wiley Online Library
![Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00604-021-04943-6/MediaObjects/604_2021_4943_Figa_HTML.png)
Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink
![Cancers | Free Full-Text | The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer Cancers | Free Full-Text | The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer](https://www.mdpi.com/cancers/cancers-12-01108/article_deploy/html/images/cancers-12-01108-g001.png)
Cancers | Free Full-Text | The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
![Nanomaterials | Free Full-Text | Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics Nanomaterials | Free Full-Text | Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics](https://pub.mdpi-res.com/nanomaterials/nanomaterials-13-02476/article_deploy/html/images/nanomaterials-13-02476-ag-550.jpg?1693581271)
Nanomaterials | Free Full-Text | Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
![Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level | British Journal of Cancer Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-023-02426-4/MediaObjects/41416_2023_2426_Figa_HTML.png)
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level | British Journal of Cancer
![Increased expression of proliferation markers and her2/neu in neuT-C3... | Download Scientific Diagram Increased expression of proliferation markers and her2/neu in neuT-C3... | Download Scientific Diagram](https://www.researchgate.net/publication/258524349/figure/fig3/AS:616384681758737@1523968968608/Increased-expression-of-proliferation-markers-and-her2-neu-in-neuT-C3--mammary-cancer.png)
Increased expression of proliferation markers and her2/neu in neuT-C3... | Download Scientific Diagram
![Frontiers | Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents Frontiers | Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents](https://www.frontiersin.org/files/Articles/1006429/fonc-12-1006429-HTML-r1/image_m/fonc-12-1006429-g001.jpg)
Frontiers | Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents
![HER2 Tumor Marker Test - - Medical Lab Tests - What is ? , Uses , Need , Preparation , Results - YouTube HER2 Tumor Marker Test - - Medical Lab Tests - What is ? , Uses , Need , Preparation , Results - YouTube](https://i.ytimg.com/vi/QHjPO2LfJ8E/sddefault.jpg)
HER2 Tumor Marker Test - - Medical Lab Tests - What is ? , Uses , Need , Preparation , Results - YouTube
![STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits](https://www.spandidos-publications.com/article_images/ijo/44/2/IJO-44-02-0403-g01.jpg)
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
![Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram](https://www.researchgate.net/publication/235604812/figure/fig1/AS:393317297737740@1470785559964/Immunohistochemical-profiles-of-ER-PR-HER2-and-Ki-67-markers-in-the-tumor-sample-from.png)
Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram
![Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships | bioRxiv Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/07/14/2020.07.14.200600/F1.large.jpg)